Introduction
============

Infertility is relatively common among young couples (10--15%) where, 45--50% is due to female factor, 30--40% results from male factor, and the remaining of cases (10--30%) is idiopathic ([@B1]). One of the treatments of idiopathic infertility is ovulation induction followed by intrauterine insemination (IUI) ([@B2]). Evidence suggests that oxidants such as active forms of oxygen are involved in occurrence of many destructive diseases and events including women fertility, menopause and fertility decline ([@B3]--[@B5]).

There is growing evidence on the effects of oxidative stress on the female genital tract, and also on infertility especially in men. In addition, the involvement of oxidative stress in the pathophysiology of preeclampsia, hydatidiform mole and birth defects has been reported ([@B3]--[@B6]).

Study in animal models has shown that acute inflammation is increased in intrautine insemination compared to natural mating, resulting in neutrophils accumulation in the uterus ([@B3]--[@B6]).

Inflammation is part of the process of implantation and may be different from inflammatory process that is followed by IUI.

In addition, human and animal model studies have demonstrated that artificial insemination might change the rate of fertility due to activation of the cholinergic system that increases myometrial contractility. Several studies demonstrated that AChE inhibitors as agricultural insecticides were associated with yet unexplained impairments in spermatogenesis and sperm quality. Thus, maybe, the reduction of acetylcholine hydrolysis in uterus and the increase in uterus motility might have an effect on fertility in women ([@B7]--[@B11]). Studies have suggested that antioxidants may help in increasing the chances of fertilization.

There are two types of human cholinesterases, acetyl cholinesterase (AChE) and butyrylcholinestrase (BuChE) ([@B12]). AChE is found in the lungs, spleen, nerve endings, gray matter of the brain and red blood cells ([@B13]) and BuChE is found in plasma, and in different organs including liver, pancreas, heart, and brain ([@B12]). BuChE cleaves choline esters including the muscle relaxants, succinylcholine, mivacurium, and their derivatives, which are strong inhibitors of red cell acetyl-cholinesterase ([@B14], [@B15]).

Association of BuChE activity with oxidative stress, inflammatory diseases such as lupus, type 2 diabetes mellitus (T2DM), cardiovascular disease, rheumatoid arthritis, preeclampsia and with abnormal lipid profile during various phases of menstrual cycle in young healthy women with regular menses is well established ([@B16]--[@B25]). However, the physiological function of BuChE has not yet fully understood ([@B12]). The performance of AChE in the nervous system as well as the co-regulatory function of acetylcholine (Ach) in relation to BuChE has been suggested ([@B13]). At present, no information on clinical significance of BuChE activity and phenotypes and its relationship with AChE activity, the marker of inflammatory (CRP), the enzymatic (superoxide dismutase, glutathione peroxidase, catalase) and/or non-enzymatic (protein thiol and total antioxidant capacity) antioxidant defense system in IUI is available. The present study has investigated the association between BuChE activity and phenotypes with AChE and oxidative stress makers before and after IUI in patients with idiopathic infertility.

Methods
=======

Subjects:
---------

The study protocol was approved by the Ethics Committee of the Kermanshah University of Medical Sciences (KUMS) and was in accordance with the principles of the Declaration of Helsinki II and all subjects provided written informed consent. The study population consisted of 60 (29.98±5.16 years old) patients with unexplained infertility that referred to the Infertility Center of the Kermanshah University of Medical Sciences for IUI.

In the present study, the kind of used catheter was Sage and easy-to-use. Sperm preparation technique that was used in this study was Discontinuous density gradient method according WHO laboratory manual ([@B26]).

Individuals with a history of illness, such as hypertension, chronic disease, myasthenia gravis, infectious diseases, cardiovascular, renal disease, diabetes, smoking and any diseases requiring medications were excluded from the study.

Chemical Analysis:
------------------

The blood samples were collected before and 24 *hr* after IUI under the fasting condition. BuChE activity and phenotypes were determined using benzoylcholine chloride (50 *μmol/l*) as substrate in the presence or absence of dibucaine hydrochloride (10 *μmol/l*) and sodium fluoride (50 *μmol/l*) as inhibitor of enzyme described previously ([@B25]). One unit of BuChE activity was defined as the amount of enzyme required to hydrolyze 1 *μmol* of benzoylcholine chloride per minute at standard assay conditions. BuChE activity, DN and FN were calculated as follows: $$\begin{array}{l}
{\text{Serum}\,\text{BuChE}\,(\text{IU}/\text{L}) = \Delta\text{A}/\mathit{\min}\, \times \, 30.3\, \times \, 10^{3}} \\
{\text{DN}\,\text{or}\,\text{FN} = (1 - \Delta\text{A}/\mathit{\min}\,\text{with}\,\text{inhibitor}/\Delta\text{A}/\mathit{\min}\,\text{without}\,\text{inhibitor}) \times 100.} \\
\end{array}$$

C- reactive protein (CRP) was measured using commercially available enzyme assay kits (Pars Azmon, Iran), using an automated Erba XL-600 (Mannheim, Germany).

Erythrocyte acetylcholinesterase activity was measured using acetylthiocholine as substrate as previously described ([@B27]). To obtain packed erythrocytes, an aliquot of blood samples containing heparin as anticoagulant was centrifuged at 500×*g* for 15 *min*. The erythrocytes were washed three times with an isotonic solution of NaCl (0.9%) until a colorless supernatant was observed. To obtain erythrocyte hemolysate, 500 *μl* of packed erythrocytes was hemolyzed by addition of four volumes of cold double distilled water. The resulting suspension was centrifuged twice to eliminate all of the cell membranes ([@B28]).

Erythrocyte SOD and GSH-Px activities and serum TAC levels were measured using commercially available kits (Randox Laboratories Ltd. Ireland). Erythrocyte CAT activity was measured by the method of Aebi et al. ([@B29]). Serum level of thiol proteins was measured using 5,5′ --dithio-bis-2-nitrobenzoic acid (DTNB) as color reagent as previously described ([@B30]).

Statistical analysis:
---------------------

Plasma BuChE activity, levels of TP and TAC levels and activities of the erythrocyte AChE, Cu-Zn SOD, GSH-Px, and CAT (normal distribution using Kolmogorov-Smirnow) were compared before and after IUI using paired t-test. The correlation values of plasma TP and CRP, and the activities of the erythrocyte AChE, Cu-Zn SOD, GSH-Px, and CAT, with BuChE activity and phenotypes before and after IUI were calculated using Pearson correlation and an independent-samples t-test. An independent-samples t-test and Pearson correlation analysis were used to compare quantitative data. Statistical significance was assumed at the p\<0.05. The SPSS statistical software package version 16 was used for the statistical analysis.

Results
=======

The mean age of participants in the study was 29.98±5.16 years and the mean body mass index (BMI) was 24.33±2.64 *Kg/m*^2^. The activities of BuChE, AChE, Cu-Zn-SOD, GSH-Px, and CAT and the plasma level of CRP, TAC and thiol proteins before and after IUI in patients are given in [table 1](#T1){ref-type="table"}. The activity of AChE in RBC decreased significantly (586.7±384.07 *vs*. 382.4±163.19 *U/grHb*, p=0.025), while the activity of SOD (1126±230 *vs*. 1568±847.5 *U/grHb*, p=0.031) and CAT (310±53.4 *IU/grHb vs*. 338±73, p=0.025) increased substantially ([Table 1](#T1){ref-type="table"}) following IUI.

###### 

The activities and levels of parameters have been compared before and after IUI in patients

  **Parameters**                                                     **Before IUI M±SD**   **After IUI M±SD**   **P-value**
  ------------------------------------------------------------------ --------------------- -------------------- -------------
  **BuChE activity [^\*^](#TFN1){ref-type="table-fn"} (*IU/l*)**     1082±259              1033±248             0.31
  **AChE activity [^\*\*^](#TFN2){ref-type="table-fn"} (*U/gHb*)**   586.7±384.1           382.4±163.2          0.025
  **SOD activity (*U/gHb*)**                                         1126±230              1568±847.5           0.031
  **GSH-Px activity (*U/gHb*)**                                      51.1±12.8             47.4±10.8            0.1
  **CAT activity (*U/gHb*)**                                         310±53.4              338±73               0.025
  **TAC (*mmol/l*)**                                                 1.24±0.139            1.23±0.221           0.51
  **TP (*μmmol/l*)**                                                 761±165               745±164              0.61
  **CRP (*mg/l*)**                                                   1.5±0.78              1.83±1.23            0.09

*μmol L*^−1^ *min*^−1^ at 25°*C*, substrate benzoylcholine chloride;

*μmol L*^−1^ *min*^−1^/*gHb* at 25°*C* of pack cell, substrate acetylthiocholine; BuChE= butyrycholinestrase; AChE=Acetylcholinestrase; CRP=C-reactive protein; SOD= superoxide dismutase; GpX=glutathione peroxidase; CAT= catalase (CAT); IUI= intrauterine insemination (IUI); TH=Thiol protein; Paired t test was used for comparing parameters before and after IUI

A negative correlation between BuChE and AChE activity (r=−0.44, p=0.045) but a positive correlation between BuChE and plasma level of TAC, following IUI (r=0.027, p=0.048) was found ([Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}). In addition, carriers of non-UU BuChE phenotypes compared to UU carriers were found to have lower BuChE and AChE, and GSH-Px activities and lower levels of plasma TAC and thiol proteins regardless of IUI status. The non-UU BuChE carriers also had higher CAT and SOD activities than UU BuChE. However, regarding the CAT activity and CRP levels, the difference was not significant ([Table 4](#T4){ref-type="table"}).

###### 

Correlation between RBC AChE activity with activities and levels of parameters separately in patients before and after IUI

  **Parameters**               **RBC-AChE activity (*U/grHb*)**   
  ---------------------------- ---------------------------------- ------------------
  **BuChE activity (*U/l*)**   r=0.18, p=0.34                     r=−0.44, p=0.045
  **TAC (*mmol/l*)**           r=0.16, p=0.38                     r=0.24, p=0.3
  **TP (*mmol/l*)**            r=0.132, p=0.46                    r=−0.029, p=0.9
  **CAT (*k/grHb*)**           r=−0.07, p=0.7                     r=−0.041, p=0.86
  **GPX (*U/grHb*)**           r=−0.052, p=0.77                   r=0.08, p=0.7
  **SOD (*U/grHb*)**           r= −0.11, p=0.53                   r=0.24, p=0.29
  **CRP (*mg/l*)**             r=−0.12, p=0.4                     r=−0.14, p=0.2

r=Pearson Correlation; BuChE=butyrycholinestrase; AChE=Acetyl-cholinestrase; CRP=C-reactive protein; SOD=superoxide dismutase; GpX= glutathione peroxidase; CAT=catalase (CAT); IUI=intrauterine insemination (IUI); TH=Thiol protein

###### 

Correlation between serum BuChE activity with activities and levels of parameters separately in patients before and after IUI

  **Parameters**                  **BuChE activity (*U/l*)**   
  ------------------------------- ---------------------------- ------------------
  **AChE activity (*U/gr Hb*)**   r=0.18, p=0.34               r=−0.44, p=0.045
  **TAC (*mmol/l*)**              r=0.27, p= 0.048             r=−0.057, p=0.68
  **TP (*mmol/l*)**               r= −0.017, p=0.9             r=−0.09, p=0.49
  **CAT (*k/grHb*)**              r=−0.061, p= 0.67            r=0.031, p=0.82
  **GPX (*U/grHb*)**              r=−0.064, p=0.64             r=0.157, p=0.26
  **SOD (*U/grHb*)**              r=−0.041, p=0.77             r=0.043, p=0.76
  **CRP (*mg/l*)**                r=−0.11, p=0.42              r=−0.25, p=0.07

r=Pearson Correlation; BuChE=butyrycholinestrase; AChE=Acetyl-cholinestrase; CRP=C-reactive protein; SOD=superoxide dismutase; GpX= glutathione peroxidase; CAT=catalase (CAT); IUI=intrauterine insemination (IUI); TH=Thiol protein

###### 

Association of BuChE phenotypes with BuChE activity, activities and levels of parameters compared between UU and non-UU groups before and after IUI

  **Parameters**                 **Before IUI**   **After IUI**                                       
  ------------------------------ ---------------- --------------- ------- ------------- ------------- -------
  **AChE activity (*U/grHb*)**   601.4±398.5      551±284.9       0.83    395±166.85    263±14.5      0.29
  **BuChE activity (*U/l*)**     1083.7±257.6     1060±338.1      0.89    1040 ±240.4   906.7±395.8   0.87
  **TAC (*mmol/l*)**             1.279±0.188      1.24±0.137      0.64    1.221±0.225   1.199±0.187   0.86
  **TP (*mmol/l*)**              817.7±73.4       745±166.1       0.45    765.4±167.4   750±104.9     0.87
  **CAT (*k/grHb*)**             308±49.2         372.2±98        0.041   336±73.8      375±72.6      0.078
  **GPX (*U/grHb*)**             51.82±12.8       43.57±9.8       0.28    48.18±10.7    41±7.2        0.26
  **SOD (*U/grHb*)**             1119±222         1134±357        0.91    1566±845.7    1577±1233     0.98
  **CRP (*mg/l*)**               1.31±0.71        1.39±0.87       0.530   1.73±1.23     1.82±1.3      0.12

Comparing parameters between BuChE phenotypes UU and non-UU by independent t test

Discussion
==========

There are growing studies on the effect of acute inflammation and oxidative stress on female infertility ([@B1], [@B5], [@B6], [@B9], [@B15]). This study is unique in that it provides important information about possible stimulation of oxidative stress and acute inflammation by IUI that may lead to reduced fertility rates through an effect on the activities of AChE, BuChE and enzymatic and non-enzymatic antioxidant systems.

A significant decrease was found in activity of AChE in RBC following IUI. Reports of animal studies have shown that intramuscular injection of acetylcholine after natural mating increased uterine contraction and decreased fertility ([@B4]--[@B6]). It has also been demonstrated that the level of AChE in RBC significantly increased during pregnancy and returned to the normal pre-pregnancy level at 6th post-partum week ([@B4]--[@B6], [@B31]), suggesting that increased activity of AChE may inhibit the action of acetylcholine in the uterus to protect the pregnancy ([@B6], [@B31]). These data collectively suggest that oxidative stress (oxidants) may help in decreasing the chances of fertilization.

In addition, BuChE activity decreased after IUI but it did not reach to a statistically significant level. However, there was a significant negative correlation between the BuChE activities with AChE activity after IUI. It could be due to increased destruction of acetylcholine, reduced uterine contraction, and increased implantation of zygotes for a successful pregnancy. Recently, it was demonstrated that BuChE activity might be involved in the pathogenesis of preeclampsia through influence on lipid and lipoprotein metabolism and oxidative stress ([@B22]).

In this study, it was found that serum CRP concentration increased and plasma TAC and TP concentrations decreased following IUI. Some studies have shown that lower TAC in seminal fluid is associated with male infertility ([@B32]). That may cause oxidative damage to membranes and reduced sperm motility. Therefore, IUI may be the cause of oxidative stress in patients. There is growing evidence about the effects of oxidative stress on the female genital tract, and also infertility especially in men ([@B1], [@B6], [@B33]). These results are consistent with the results of previous studies ([@B1], [@B6], [@B33], [@B34]), demonstrating that oxidative stress (overproduction of ROS) may have an effect on female reproduction by disturbance of human oocyte intracellular Ca^2+^ homeostasis as well as oocyte maturation and fertilization. The bulk of evidence at the present time indicates that inflammation of the endometrium may reduce fertility and implantation of a fertilized ovum ([@B35]). Thus, the increase in CRP might be inversely related with the efficiency of IUI fertility. Tamura et al. demonstrated that the administration of melatonin resulted in reduced intra-follicular oxidative damage and a net elevation of fertilization and pregnancy rates ([@B36]).

Therefore, oxidative stress is involved in oocyte quality, and its degree can be evaluated by biomarkers of TAC, thiol proteins and lipid peroxidation ([@B37]). These findings suggest that reduced antioxidant capacity of semen could be responsible for infertility.

The antioxidant and detoxification properties of BuChE directly correlate with its activity. Therefore, individuals with abnormal phenotypes of BuChE (non-UU phenotype with low BuChE activity) may be more susceptible to oxidative stress and may have a lower fertility rate when using IUI.

Conclusion
==========

Results of this study demonstrated that IUI, due to increasing oxidative stress and decreasing cholinesterases activities, leads to increase in the action of acetylcholine on the uterus and may increase uterine contraction and motility and decrease fertility. However, because of the heterogeneous picture of IUI due to increased oxidative stress, acute inflammation and the influence of a subset of risk factors, in the treatments, IUI was used for infertile couples. Therefore, further studies with greater number of patients would be required to shed light on the contribution of non-UU phenotypes of BuChE and enzymatic activity such as BuChE, AChE, SOD, CAT and serum levels of TAC, TP and CRP for treatment of infertile couples in different ethnicities.
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